Latest Insider Transactions at Vanda Pharmaceuticals Inc. (VNDA)
This section provides a real-time view of insider transactions for Vanda Pharmaceuticals Inc. (VNDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vanda Pharmaceuticals Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vanda Pharmaceuticals Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2022
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
48,250
-3.32%
|
$482,500
$10.61 P/Share
|
|
Dec 06
2022
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,365
+4.92%
|
$226,095
$3.12 P/Share
|
|
Dec 05
2022
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
47,650
-3.34%
|
$476,500
$10.62 P/Share
|
|
Dec 05
2022
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
74,635
+4.97%
|
$223,905
$3.12 P/Share
|
|
Aug 26
2022
|
Gunther Birznieks SVP, Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.65%
|
$3,750
$3.12 P/Share
|
|
Aug 22
2022
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
3,605
-3.6%
|
$36,050
$10.27 P/Share
|
|
Aug 15
2022
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
8,300
-4.08%
|
$83,000
$10.32 P/Share
|
|
Jul 28
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
2,239
-1.87%
|
$22,390
$10.97 P/Share
|
|
Jun 16
2022
|
Phaedra Chrousos |
BUY
Grant, award, or other acquisition
|
Direct |
12,006
+32.5%
|
-
|
|
Jun 16
2022
|
Richard W Dugan |
BUY
Grant, award, or other acquisition
|
Direct |
12,006
+12.99%
|
-
|
|
Jun 16
2022
|
Stephen Ray Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
12,006
+39.33%
|
-
|
|
Jun 16
2022
|
Anne Sempowski Ward |
BUY
Grant, award, or other acquisition
|
Direct |
12,006
+35.3%
|
-
|
|
Jun 13
2022
|
Stephen Ray Mitchell |
SELL
Open market or private sale
|
Direct |
2,700
-29.3%
|
$24,300
$9.48 P/Share
|
|
Jun 02
2022
|
Thomas Watkins Director |
SELL
Open market or private sale
|
Direct |
6,441
-9.27%
|
$57,969
$9.9 P/Share
|
|
Jun 02
2022
|
Thomas Watkins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+17.75%
|
$60,000
$4.15 P/Share
|
|
May 31
2022
|
Richard W Dugan |
SELL
Open market or private sale
|
Direct |
6,500
-8.68%
|
$58,500
$9.85 P/Share
|
|
May 31
2022
|
Richard W Dugan |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+16.69%
|
$60,000
$4.15 P/Share
|
|
Mar 02
2022
|
Gunther Birznieks SVP, Business Development |
SELL
Open market or private sale
|
Direct |
11,517
-5.75%
|
$126,687
$11.27 P/Share
|
|
Mar 02
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
8,832
-6.87%
|
$97,152
$11.28 P/Share
|
|
Mar 02
2022
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
29,588
-2.14%
|
$325,468
$11.15 P/Share
|
|
Mar 02
2022
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,974
-6.5%
|
$76,714
$11.19 P/Share
|
|
Mar 02
2022
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
12,060
-10.4%
|
$132,660
$11.09 P/Share
|
|
Mar 01
2022
|
Gunther Birznieks SVP, Business Development |
SELL
Open market or private sale
|
Direct |
4,084
-2.0%
|
$44,924
$11.19 P/Share
|
|
Mar 01
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
3,473
-2.63%
|
$38,203
$11.19 P/Share
|
|
Mar 01
2022
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
7,508
-0.54%
|
$82,588
$11.19 P/Share
|
|
Feb 28
2022
|
Gunther Birznieks SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+13.79%
|
-
|
|
Feb 28
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+19.85%
|
-
|
|
Feb 28
2022
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
115,000
+7.64%
|
-
|
|
Feb 28
2022
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+23.37%
|
-
|
|
Feb 28
2022
|
Timothy Williams SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+22.0%
|
-
|
|
Dec 01
2021
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
46,200
-3.5%
|
$739,200
$16.0 P/Share
|
|
Dec 01
2021
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
71,676
+5.15%
|
$286,704
$4.88 P/Share
|
|
Nov 30
2021
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-3.85%
|
$800,000
$16.49 P/Share
|
|
Nov 30
2021
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
78,324
+5.69%
|
$313,296
$4.88 P/Share
|
|
Sep 15
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
16,824
-17.03%
|
$269,184
$16.49 P/Share
|
|
Sep 15
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,119
+5.92%
|
$133,309
$11.8 P/Share
|
|
Sep 09
2021
|
Stephen Ray Mitchell |
SELL
Open market or private sale
|
Direct |
19,109
-67.47%
|
$305,744
$16.74 P/Share
|
|
Sep 09
2021
|
Stephen Ray Mitchell |
BUY
Exercise of conversion of derivative security
|
Direct |
19,109
+29.96%
|
$210,199
$11.64 P/Share
|
|
Aug 20
2021
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
3,650
-4.67%
|
$54,750
$15.39 P/Share
|
|
Aug 16
2021
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,715
-4.27%
|
$59,440
$16.15 P/Share
|
|
Jul 28
2021
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
2,130
-2.1%
|
$40,470
$19.24 P/Share
|
|
Jul 26
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
7,250
-7.72%
|
$137,750
$19.69 P/Share
|
|
Jun 15
2021
|
Stephen Ray Mitchell |
SELL
Open market or private sale
|
Direct |
5,000
-35.17%
|
$95,000
$19.42 P/Share
|
|
Jun 15
2021
|
Stephen Ray Mitchell |
BUY
Exercise of conversion of derivative security
|
Direct |
4,015
+22.02%
|
$40,150
$10.57 P/Share
|
|
Jun 14
2021
|
Phaedra Chrousos |
SELL
Open market or private sale
|
Direct |
2,075
-13.83%
|
$39,425
$19.34 P/Share
|
|
Jun 10
2021
|
Phaedra Chrousos |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+25.0%
|
-
|
|
Jun 10
2021
|
Richard W Dugan |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+7.71%
|
-
|
|
Jun 10
2021
|
Stephen Ray Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+32.89%
|
-
|
|
Jun 10
2021
|
Anne Sempowski Ward |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+33.33%
|
-
|
|
Jun 10
2021
|
Thomas Watkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.4%
|
-
|